Abstract |
Laryngeal cancer is one of the most common head and neck malignant tumors and is commonly resistant to X-ray-based radiotherapy. NF-κB interacting lncRNA (NKILA) has been reported to serve as a tumor suppressor in several cancers through combining with NF-κB: IκB complex thereby inhibiting NF-κB activation. Herein, we demonstrated a low NKILA expression in laryngeal cancer and its correlation with shorter overall survival in patients with laryngeal cancer. NKILA serves as a tumor suppressor in laryngeal cancer by suppressing laryngeal cancer cell viability and migration, whereas promoting cell apoptosis; NKILA knockdown reverses the cytotoxicity of X-ray radiation on laryngeal cancer cells through combining with NF-κB: IκB complex to inhibit IκB phosphorylation, inhibit p65 nuclear translocation, and finally inhibit NF-κB activation. NF-κB binds to the promoter region of NKILA to activate its transcriptional activity, upregulated NKILA then inhibits IκB phosphorylation and NF-κB activation, thus forming a negative feedback loop to sensitize laryngeal cancer cell to X-ray radiation. In conclusion, NKILA can serve as a promising agent of enhancing the cytotoxicity of X-ray radiation on laryngeal cancer and addressing the radioresistance of laryngeal cancer.
|
Authors | Tao Yang, Shisheng Li, Jiajia Liu, Danhui Yin, Xinming Yang, Qinglai Tang |
Journal | Cancer medicine
(Cancer Med)
Vol. 7
Issue 5
Pg. 2048-2063
(05 2018)
ISSN: 2045-7634 [Electronic] United States |
PMID | 29573243
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. |
Chemical References |
- RELA protein, human
- RNA, Long Noncoding
- Transcription Factor RelA
- long noncoding RNA NKILA, human
- I-kappa B Kinase
|
Topics |
- Cell Line, Tumor
- Cell Movement
(genetics)
- Cell Proliferation
(genetics)
- Enzyme Activation
(genetics)
- Female
- Gene Expression
(genetics)
- Humans
- I-kappa B Kinase
(metabolism)
- Laryngeal Neoplasms
(genetics, mortality, radiotherapy)
- Male
- Middle Aged
- Phosphorylation
(genetics)
- Promoter Regions, Genetic
(genetics)
- RNA, Long Noncoding
(genetics)
- Radiation Tolerance
(genetics)
- Transcription Factor RelA
(genetics)
|